Compare GKOS & PDFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GKOS | PDFS |
|---|---|---|
| Founded | 1998 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 1.2B |
| IPO Year | 2015 | N/A |
| Metric | GKOS | PDFS |
|---|---|---|
| Price | $115.81 | $29.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 4 |
| Target Price | ★ $126.38 | $34.50 |
| AVG Volume (30 Days) | ★ 694.2K | 260.4K |
| Earning Date | 10-29-2025 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $469,820,000.00 | $206,706,000.00 |
| Revenue This Year | $31.15 | $24.23 |
| Revenue Next Year | $24.15 | $19.28 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 30.38 | 21.23 |
| 52 Week Low | $73.16 | $15.91 |
| 52 Week High | $163.71 | $32.31 |
| Indicator | GKOS | PDFS |
|---|---|---|
| Relative Strength Index (RSI) | 71.98 | 55.68 |
| Support Level | $115.07 | $28.35 |
| Resistance Level | $117.94 | $29.25 |
| Average True Range (ATR) | 2.91 | 1.14 |
| MACD | -0.13 | -0.17 |
| Stochastic Oscillator | 81.29 | 43.35 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
PDF Solutions Inc offers products and services designed to empower engineers and data scientists across the semiconductor ecosystem to improve the yield, quality, and profitability of their products. The solutions combine proprietary software, physical intellectual property (or IP) for integrated circuit (or IC) designs, electrical measurement hardware tools, various methodologies, and professional services. The company's products and services are sold to integrated device manufacturers (or IDMs), fabless semiconductor companies, foundries, outsourced semiconductor assembly and test (or OSATs), and system houses.